Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Neurology. 2016 Sep 6;87(10):1066. doi: 10.1212/01.wnl.0000497026.62085.8d.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fingolimod Hydrochloride
  • Humans
  • Multiple Sclerosis, Relapsing-Remitting*
  • Natalizumab
  • Propylene Glycols

Substances

  • Natalizumab
  • Propylene Glycols
  • Fingolimod Hydrochloride